09.26.24 -- Understanding Excipient-Influenced mAb Dynamics At The Atomic Level

Ben Stevens of GSK documents his career, and highlights a stage in outsourcing we often overlook –  key interactions between med-chem scientists and research biologists, and contract development and manufacturing providers (CDMOs).

Our moderator and panelists get into quite an open discussion about whether to select bigger, multi-service providers, or more focused external partners known as best-in-class in specific services he need.

Discover how customizable laboratory services are revolutionizing oncology trials by enabling precision medicine and enhancing patient outcomes through flexible, innovative trial designs.

As recombinant protein-based products accelerate toward IND, reliable process development methods are critical to meet demand. Review case studies to learn how expedited timelines can be achieved.

Orphan drug development is a journey marked by challenges at every step. From patient recruitment to aseptic fill finish, overcoming hurdles is critical for bringing life-saving treatments to market.

To receive the most comprehensive project proposal possible, it is important to fill out any questionnaire as accurately and completely as possible.

Implementing a strategic approach to optimize your platform can establish a solid foundation for the efficient, reliable, and successful manufacturing of biopharmaceutical products.

Rapid development of high-quality cell lines is vital to biomanufacturing projects. How developers approach the fundamental steps can define their core biologics capabilities and keep projects on track.

Development of RNA-based therapies sits at the cutting edge of vaccine and oncology innovation, in addition to holding promise in dozens of other therapeutic areas.

Automated manufacturing is a powerful but often misunderstood tool available to produce drug delivery and other pharmaceutical devices — whether established designs or innovative new ideas.

By investing in the establishment and maintenance of a high-quality master cell bank, developers can set themselves up for long-term success and ensure supply chain sustainability.

Discover strategies to address challenges occurring during the development of molecular formats such as chain assembly, multiple-MoAs, and diverse post-translational modifications.

Explore how the optimization of Interactive Response Technologies (IRT) settings relieved the burden of managing global supply needs for a CRO customer and clinical sponsor.

Learn how end-to-end support for development and manufacturing, clinical trial services, advanced drug delivery, and commercial packaging can accelerate drug development and time to market.

Join the next Outsourced Pharma Live as our panel explores the critical considerations and best practices for selecting and managing CDMOs in the development of novel therapies, including advanced therapy medicinal products like cell and gene therapies. Industry experts will share insights on evaluating CDMO capabilities, ensuring quality and compliance, and fostering effective partnerships to accelerate innovation while mitigating risks.

Whether used for primary or secondary endpoints or in exploratory research, our seasoned scientists provide rigorous and scientifically robust support to ensure the successful application of biomarker assays.

An affinity chromatography resin for purifying recombinant proteins using the self-cleaving Cytiva™ Protein Select™ tag.

Review our capabilities in tech transfer, clinical drug substance, and commercial drug substance manufacturing across our manufacturing network in Singapore, Europe, and the US.

Explore our fill line capabilities, including vial and syringe handling. Schedule a tour of our DP filling facility in Denmark. Our experienced team is available to discuss your needs.

Scaling your drug product from concept to commercial supply requires having the expertise to ask the right questions about your end goals, from the start.